Lower Respiratory Tract Disease in Children: Constant Pathogens – Constant Management?!

Abstract

Background: This study analyses the pathogens of acute lower respiratory tract infections (LRI) in children in a German community hospital over six years. Against this background the adoption of new diagnostic and therapeutic guidelines for the LRI management and of RSV-cases in particular is studied.

Methods: 1054 children aged zero to 36 months hospitalized with LRI were prospectively included in the surveillance studies “Parainfluenzavirus (PIV) and Respiratory syncytial virus (RSV) infections in Germany [PRI.de] 1999–2001” and the “pediatric infectious diseases network on acute respiratory tract infections” [PID-ARI.net] for the time period of October 2002 until June 2005. The nasopharyngeal aspirates (NPA) of these children had been analysed for RSV, PIV 1,2,3 and influenzavirus (IV)-A, -B. In 2003/2004 the national guideline on how to diagnose and treat RSV-disease (bronchiolitis) changed. Data on LRI cases severity and especially those regarding the clinical management of RSV-infections were compared to see differences following the release of the guideline.

Results: 84% of the children were between zero and 24 months old. 34% of the NPA specimens were positive for RSV, 7.7% for PIV 1,2,3 and 4.7% for IV-A, -B. Epidemiological findings did not differ substantially between the two studies. Clinical management of RSV-LRI, especially drug use, did not change except for the lower rate of x-ray examination (p<0.01).

Conclusion: The spectrum of causing agents in LRI of children remained quite stable over of six years. Diagnostic and therapeutic concepts remain also stable in a situation where new guidelines were introduced, but not reinforced.

Zusammenfassung

Hintergrund: Die vorliegende Studie beschäftigt sich mit unteren Atemwegsinfektionen bei Kindern in einem deutschen Krankenhaus über den Zeitraum von sechs Jahren. Neben den auslösenden Erregern wird die Umsetzung der aktuellen therapeutischen und diagnostischen Leitlinien (LL) für die Behandlung von akuten unteren Atemwegsinfektionen am Beispiel von RSV-Infektionen untersucht.

Methoden: 1054 Kinder, die im Alter zwischen 0 und 36 Monaten wegen einer akuten unteren Atemwegsinfektion hospitalisiert waren, wurden prospektiv in die Studien „Parainfluenzavirus (PIV) und Respiratory-Syncytial-Virus (RSV) infections in Germany [PRI.de] 1999–2001” und „Pediatric infectious diseases network on acute respiratory tract infections [PID-ARI.net] 2002–2005” eingeschlossen. Das Nasopharyngealsekret (NPS) von diesen Kindern wurde auf RSV-, PIV 1,2,3 und Influenzavirus(IV) A und B untersucht. Die LL zur Diagnostik und Behandlung von RSV-Infektionen (Bronchiolitis) änderten sich 2003/2004. Die Daten der Kinder mit akuten unteren Atemwegsinfektionen und im Speziellen die therapeutischen und diagnostischen Maßnahmen bei Kindern mit RSV-Infektionen wurden zwischen beiden Studien verglichen, um den Einfluss der LL-Änderung zu verfolgen.

Ergebnisse: 84% der Kinder waren zwischen null und 24 Monaten alt. 34% der NPS-Proben waren positiv für RSV, 7.7% für PIV 1,2,3 und 4.7% für IV-A und -B. Die epidemiologischen Daten unterscheiden sich nicht wesentlich zwischen den beiden Studien. Das therapeutische Vorgehen bei durch RSV bedingten unteren Atemwegsinfektionen änderte sich nicht. Röntgen-Thorax-Untersuchungen wurden in der späteren Studie weniger angefordert (p<0.01).

Schlussfolgerung: Das Spektrum der verantwortlichen Erreger für akute untere Atemwegsinfektionen bei Kindern blieb weitgehend stabil über sechs Jahre. Die diagnostischen und therapeutischen Konzepte waren ebenfalls gleichbleibend trotz neuer LL, die bekannt gemacht, nicht aber speziell implementiert wurden.

respiratory pathogens - respiratory syncytial virus - lower respiratory tract infection - childhood

respiratorische Pathogene - respiratorischer Syncytial-virus - untere Atemwegsinfektion - Kindheit

Literatur

• 1 AWMF-Leitlinien . Obstruktive Bronchitis in den ersten 3 Lebensjahren (inkl. Bronchiolitis), AWMF-Leitlinien-Register Nr 026/00.  http://(www.uni-duesseldorf.de/WWW/AWMF/ll-na/026-009.htm) , (14.3.2007)
• 2 Berner R, Schwoerer F, Schumacher RF, Meder M, Forster J. Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999.  Eur J Pediatr. 2001;  160 541-547
• 3 Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a meta-analysis.  Pediatr Crit Care Med. 2004;  5 ((5)) 482-489
• 4 Denny FD, Clyde WA. Acute lower respiratory tract infections in non hospitalized children.  J Pediatr. 1986;  108 635-646
• 5 DGPI (German Society for Pediatric Diseases) .Respiratory syncytial virus (RSV)-Infektionen, and: Bronchiolitis, in DGPI (German Society for Pediatric Diseases): Infektionen bei Kindern und Jugendlichen. 4th edition, Futuramed Verlag, Muenchen 2003 pp 599–603, and pp773–774
• 6 Forster J, Ihorst G, Rieger CH, Stephan V, Frank HD, Gurth H, Berner R, Rohwedder A, Werchau H, Schumacher M, Tsai T, Petersen G. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study).  Eur J Pediatr. 2004;  163 709-716
• 7 Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries.  World Health Stat Q. 1992;  45 180-191
• 8 Grondahl B, Puppe W, Hoppe A, Kuhne I, Weigl JA, Schmitt HJ. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study.  J Clin Microbiol. 1999;  37 1-7
• 9 Hall CB. Respiratory syncytial virus. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia 2000 pp 2084-2111
• 10 Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. A meta-analysis of randomized controlled trials evaluating the efficacy o epinephrine for the treatment of acute viral bronchiolitis.  Arch Pediatr Adolesc Med. 2003;  157 ((10)) 957-964
• 11 Hindiyeh M, Hillyard DR, Carroll KC. Evaluation of the Prodesse Hexaplex multiplex PVR assay for direct detection of seven respiratory viruses in clinical specimens.  Am J Clin Pathol. 2001;  116 218-224
• 12 Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.  Pediatrics. 2004;  113 1758-1764
• 13 Kehl SC, Henrickson KJ, Hua W, Fan J. Evaluation of the Hexaplex assay for detection of respiratory viruses in children.  J Clin Microbiol. 2001;  39 696-701
• 14 Kimpen JL, Schaad UB. Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases.  Pediatr Infect Dis J. 1997;  16 ((5)) 479-481
• 15 Kotagal UR, Robbins JM, Kini NM, Schoettker PJ, Atherton HD, Kirschbaum MS. Impact of a bronchiolitis guideline: a multisite demonstration project.  Chest.. 2002;  121 ((6)) 1789
• 16 Kuilboer MM, van Wijk MA, Mosseveld M, van der Does E, de Jongste JC, Overbeek SE, Ponsioen B, van der Lei J. Computed critiquing integrated into daily clinical practice affects physicians’ behavior–a randomized clinical trial with AsthmaCritic.  Methods Inf Med. 2006;  45 ((4)) 447-454
• 17 Lanari M, Giovannini M, Giuffre L, Marini A, Rondini G, Rossi GA, Merolla R, Zuccotti GV, Salvioli GP. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.  Pediatr Pulmonol. 2002;  33 458-465
• 18 Leowski J. Mortality from acute respiratory infections in children under 5 years of age Global estimates.  Worl Health Stat Q. 1986;  39 138-144
• 19 Liolios L, Jenney A, Spelman D, Kotsimbos T, Catton M, Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridisation assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.  J Clin Microbiol. 2001;  39 2779-2783
• 20 Michaud CM, Murray CJL, Bloom BR. Burden of disease- implication for future research.  JAMA. 2001;  285 534-539
• 21 Mitchell EA, Didsbury PB, Kruithof N, Robinson E, Milmine M, Barry M, Newman J. A randomized controlled trial of an asthma clinical pathway for children in general practice.  Acta Paediatr.. 2005;  94 ((2)) 226-233
• 22 Parrott RH, Kim WH, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.  Am J Epidemiol. 1973;  98 289-300
• 23 Puppe W, Weigl JA, Aron G, Grondahl B, Schmitt HJ, Niesters HG, Groen J. Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens.  J Clin Virol. 2004;  30 165-174
• 24 Swinger GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children.  Lancet. 1998;  1351 404-408
• 25 Weigl JAI, Puppe W, Grondahl B, Schmitt H-J. Epidemiological Investigation of Nine Respiratory Pathogens in Hospitalized Children in Germany Using Multiplex Reverse-Transcriptase Polymerase Chain Reaction.  Eur J Clin Microiol Infect Dis. 2000;  19 336-343
• 26 Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalizations in children in Germany.  Epidemiol Infect. 2002;  129 525-553
• 27 Weigl J, Forster J, Berner R, Puppe W, Neumann-Haefelin D, Meyer C, Zepp F, Schmitt HJ. Virale Atemwegsinfektionen mit saisonaler Häufung bei Kindern.  Bundesgesundheitsblatt. 2003;  46 9-19
• 28 Weigl JA, Puppe W, Meyer CU, Berner R, Forster J, Schmitt HJ, Zepp F. RSV-prevention in children guided by a web-based early warning system.  Klin Padiatr. 2005a;  217 47-52
• 29 Weigl JA, Puppe W, Belke O, Neususs J, Bagci F, Schmitt HJ. The descriptive epidemiology of severe lower respiratory tract infections in children in Kiel, Germany.  Klin Padiatr. 2005b;  217 259-267
• 30 Weigl JA, Puppe W, Meyer CU, Berner R, Forster J, Zepp F, Schmitt HJ. Ten years experience with year-round active surveillance of up to 19 respiratory pathogens in children.  Eur J Pediatr. 2007;  166 957-966
• 31 Wickman M, Farahmand BY, Persson P-G, Pershagen G. Hospitalization for lower respiratory disease during 20 years among under-5-year-old children in Stockholm Country: a population-based survey.  Eur Respir J. 1998;  11 366-370

Correspondence